Sydney - Thursday - August 28: (RWE Australian Business News) -
Progen Pharmaceuticals (ASX:PGL) reports a strong cash balance of $76.7m
and net tangible assets of $1.19 per share.
The consolidated loss for the year totalled $26.1m (2007:
$22.5m) on operating revenues of $7.8m (2007: $3.8m). The loss was
impacted by a $3.8m unrealised foreign currency charge due to the
Company holding significant USD cash and cash equivalents and $4.0m
being expensed in relation to the unwind of the Medigen strategic
alliance.
progen cashed up but in the red
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.30M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 44.5¢ | 44.5¢ | $118.0K | 265.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1168583 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 140029 | 7 |
View Market Depth
| Last trade - 15.47pm 30/07/2024 (20 minute delay) ? |
| PGL (ASX) Chart |